NO20021441D0 - Antibody dye conjugates for binding to target structures of angiogenesis to intraoperatively map tumor peripheries - Google Patents

Antibody dye conjugates for binding to target structures of angiogenesis to intraoperatively map tumor peripheries

Info

Publication number
NO20021441D0
NO20021441D0 NO20021441A NO20021441A NO20021441D0 NO 20021441 D0 NO20021441 D0 NO 20021441D0 NO 20021441 A NO20021441 A NO 20021441A NO 20021441 A NO20021441 A NO 20021441A NO 20021441 D0 NO20021441 D0 NO 20021441D0
Authority
NO
Norway
Prior art keywords
intraoperatively
angiogenesis
binding
target structures
dye conjugates
Prior art date
Application number
NO20021441A
Other languages
Norwegian (no)
Other versions
NO20021441L (en
Inventor
Michael Schirner
Kai Licha
Ludger Dinkelborg
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7924318&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20021441(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20021441D0 publication Critical patent/NO20021441D0/en
Publication of NO20021441L publication Critical patent/NO20021441L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0058—Antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0039—Coumarin dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO20021441A 1999-09-24 2002-03-22 Antibody-dye conjugates to angiogenesis target structures for intraoperative presentation of tumor peripheries NO20021441L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19947559A DE19947559A1 (en) 1999-09-24 1999-09-24 Antibody-dye conjugates against target structures of angiogenesis for intraoperative tumor border imaging
PCT/EP2000/008121 WO2001023005A1 (en) 1999-09-24 2000-08-19 Antibody dye conjugates for binding to target structures of angiogenesis in order to intraoperatively depict tumor peripheries

Publications (2)

Publication Number Publication Date
NO20021441D0 true NO20021441D0 (en) 2002-03-22
NO20021441L NO20021441L (en) 2002-05-15

Family

ID=7924318

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021441A NO20021441L (en) 1999-09-24 2002-03-22 Antibody-dye conjugates to angiogenesis target structures for intraoperative presentation of tumor peripheries

Country Status (23)

Country Link
EP (2) EP1214099A1 (en)
JP (1) JP2003510294A (en)
KR (2) KR100832937B1 (en)
CN (1) CN1269530C (en)
AU (1) AU779026B2 (en)
BG (1) BG65682B1 (en)
BR (1) BR0014192A (en)
CA (1) CA2385593A1 (en)
CZ (1) CZ2002991A3 (en)
DE (1) DE19947559A1 (en)
EE (1) EE05176B1 (en)
HK (1) HK1050491A1 (en)
HU (1) HUP0202625A2 (en)
IL (2) IL148405A0 (en)
MX (1) MXPA02002639A (en)
NO (1) NO20021441L (en)
NZ (1) NZ517944A (en)
RO (1) RO121598B1 (en)
RU (1) RU2002109237A (en)
SK (1) SK3972002A3 (en)
WO (1) WO2001023005A1 (en)
YU (1) YU20702A (en)
ZA (1) ZA200203225B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001062800A1 (en) 2000-02-24 2001-08-30 Eidgenössische Technische Hochschule Zürich Antibody specific for the ed-b domain of fibronectin, conjugates comprising said antibody, and their use for the detection and treatment of angiogenesis
US6440389B1 (en) * 2000-07-19 2002-08-27 The General Hospital Corporation Fluorescent agents for real-time measurement of organ function
AT413487B (en) * 2002-08-12 2006-03-15 Igeneon Krebs Immuntherapie USE OF ANTIBODIES TO TUMOR ASSOCIATED ANTIGEN
NO20034351D0 (en) * 2003-09-29 2003-09-29 Amersham Health As Optical imaging of endometriosis
EP1816475A1 (en) * 2004-07-22 2007-08-08 Bayer Schering Pharma Aktiengesellschaft Use of cyanine dyes for the diagnosis of disease associated with angiogenesis
EP1679082A1 (en) * 2005-01-07 2006-07-12 Schering AG Use of cyanine dyes for the diagnosis of proliferative diseases
EP2422187A4 (en) * 2009-04-21 2013-01-02 Univ Utah Res Found Light-emitting dye for intraoperative imaging or sentinel lymph node biopsy
EP3493855A4 (en) * 2016-08-02 2020-04-01 ISI Life Sciences, Inc. Compositions and methods for detecting cancer cells in a tissue sample

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341223A (en) * 1981-02-04 1982-07-27 Lutz Lauralee A Fluoresceable composition and method of determining fluid flow
ATE198712T1 (en) * 1994-07-11 2001-02-15 Univ Texas METHODS AND COMPOSITIONS FOR THE SPECIFIC COAGULATION OF TUMOR VESSELS
TWI259837B (en) * 1998-05-11 2006-08-11 Eidgenossische Tech Hochscule Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis

Also Published As

Publication number Publication date
BG65682B1 (en) 2009-06-30
EP1532988A2 (en) 2005-05-25
WO2001023005A1 (en) 2001-04-05
EP1532988A3 (en) 2008-09-17
HK1050491A1 (en) 2003-06-27
BG106528A (en) 2002-12-29
CN1269530C (en) 2006-08-16
EE200200152A (en) 2003-04-15
NO20021441L (en) 2002-05-15
EE05176B1 (en) 2009-06-15
DE19947559A1 (en) 2001-04-19
NZ517944A (en) 2004-06-25
AU6702600A (en) 2001-04-30
YU20702A (en) 2005-06-10
CZ2002991A3 (en) 2002-06-12
ZA200203225B (en) 2003-07-23
JP2003510294A (en) 2003-03-18
KR100832937B1 (en) 2008-05-27
BR0014192A (en) 2002-05-21
AU779026B2 (en) 2005-01-06
RU2002109237A (en) 2003-11-27
KR20020039349A (en) 2002-05-25
IL148405A0 (en) 2002-09-12
CA2385593A1 (en) 2001-04-05
SK3972002A3 (en) 2002-09-10
HUP0202625A2 (en) 2002-12-28
PL354027A1 (en) 2003-12-15
CN1376074A (en) 2002-10-23
RO121598B1 (en) 2007-12-28
EP1214099A1 (en) 2002-06-19
IL148405A (en) 2009-06-15
MXPA02002639A (en) 2002-07-30
KR20070087232A (en) 2007-08-27

Similar Documents

Publication Publication Date Title
NO20021441D0 (en) Antibody dye conjugates for binding to target structures of angiogenesis to intraoperatively map tumor peripheries
IS6375A (en) Administration of prostate cancer stimulation
NO20022681D0 (en) Continuous preparation of silica-based microgels
DE69727908D1 (en) Tumor necrosis factor related receptor, TR6
IS6765A (en) Aryl or heteroaryl conjugated imidazole compounds for anti-inflammatory and analgesic agents
NO20025792L (en) Quinazoline derivatives for the treatment of tumors
IS2468B (en) Methods and Intermediates for the Preparation of Cancer Compounds
AU3041100A (en) Binding of antibody fragments to solid supports
ATE326470T1 (en) NEW AZA-INDOLYL DERIVATIVES
ID29223A (en) NEW MAP OR BINDER TO CONTROL DRUG ABSORPTION
MA25850A1 (en) CONJUGATES OF PHOTOLABLE PRO-PERFUMES.
DK1237584T3 (en) Receptor binding conjugates
NO20014105D0 (en) Texan derivatives for targeted cancer therapy
NO20014607L (en) Compositions for improving fertility
NO20011674D0 (en) Strapless toe lock binding for snowboards
NO20015828D0 (en) Methods for Preparation of 5 'Nucleic Acid Protein Conjugates
DK0942754T3 (en) Conjugates useful for the treatment of prostate cancer
NO20015227D0 (en) Steps to increase the effectiveness of anti-cancer agents
ATE434619T1 (en) THIENODIBENZAZULENE COMPOUNDS AS TUMOR NECROSIS FACTOR INHIBITORS
IS5502A (en) Conjugated compounds useful in the treatment of prostate cancer
NO20016151D0 (en) Preparation of substituted piperidin-4-ones
EE200200473A (en) Novel colon cancer specific antibody
NO20005322L (en) Steps to Increase the Efficiency of Trading
WO2001028593A3 (en) Conjugates useful in the treatment of prostate cancer
PT1030319E (en) TOROIDAL NUCLEUS